Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
To compare the anti-inflammatory efficacy of ketorolac of tromethamine 0.4% and nepafenac
0.1% eye drops for prophylaxis of cystoid macular edema (CME) after small-incision cataract
extraction.